Exercise for Prostate Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if exercise can reduce the number of cancer cells in the blood for men with advanced prostate cancer. Participants will follow a guided exercise program for 12 weeks and track their activities. The trial targets men with metastatic prostate cancer who are on specific medications and have a rising PSA, a marker of prostate health.
As an unphased trial, this study provides a unique opportunity to contribute to groundbreaking research on exercise and cancer management.
Will I have to stop taking my current medications?
The trial does not require you to stop your current medications. In fact, you need to be on androgen deprivation therapy or an oral androgen axis inhibitor for at least 3 months to participate.
What prior data suggests that this exercise intervention is safe for men with advanced prostate cancer?
In a previous study, experts found that exercise during cancer treatment reduced tiredness and improved quality of life. Another study showed that physical activity lowered the risk of dying from prostate cancer by 30%. Exercise also improved physical abilities.
No evidence suggests that exercise negatively affects prostate cancer patients. Instead, staying active might reduce the risk of the cancer worsening. Therefore, the exercise treatment in this trial is likely safe and could benefit those with advanced prostate cancer.12345Why are researchers excited about this trial?
Unlike traditional treatments for prostate cancer, such as surgery, radiation, and hormone therapy, the exercise intervention is unique because it focuses on enhancing the patient's physical activity as a form of therapy. This approach is exciting because it aims to improve overall health and potentially mitigate some side effects of conventional treatments, like fatigue and muscle loss. By personalizing an exercise program and adjusting it over time, researchers hope to show that staying active can positively impact the well-being of prostate cancer patients.
What evidence suggests that exercise intervention is effective for reducing circulating tumor cells in advanced prostate cancer?
Research has shown that regular exercise greatly benefits men with prostate cancer. In this trial, participants will follow a prescribed exercise program for 12 weeks. Studies have found that active prostate cancer survivors have a 30–60% lower risk of dying from the disease. Exercise also improves erectile function compared to those who do not exercise. Additionally, exercise can reduce the side effects of treatments like androgen deprivation therapy, which often alters body shape. Overall, exercise consistently links to better health outcomes for men with prostate cancer.56789
Who Is on the Research Team?
Cathy Marshall, MD
Principal Investigator
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Are You a Good Fit for This Trial?
Men under 80 with advanced prostate cancer, currently on androgen deprivation therapy for at least 3 months, can join this trial. They should have circulating tumor cells (CTC) present, an ECOG performance status of 0 or 1, and if seeing a cardiologist, must be cleared to participate. Prior treatments are allowed.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Exercise Intervention
Participants adhere to a prescribed exercise program for 12 weeks, with assessments and adjustments at Week 5 and Week 9
Follow-up
Participants undergo follow-up assessments 12 weeks after the exercise intervention and are monitored for vital status for 365 days
What Are the Treatments Tested in This Trial?
Interventions
- Exercise Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Lead Sponsor
Physical Medicine & Rehabilitation Educ Research Foundation, Inc
Collaborator